Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Abietic acid from pine resin can effectively inhibit testosterone 5α-reductase.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Alpha-blockers and Finasteride effectively manage BPH symptoms long-term.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

Finasteride may improve prostate cancer treatment outcomes.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Finasteride does not negatively affect male reproductive function.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.